Phase 1a Safety and Pharmacokinetics ... - HFI Connect - Hep...

HFI Connect - Hepatitis

960 members1,215 posts

Phase 1a Safety and Pharmacokinetics of NVR 3-778, a Potential First-In-Class HBV Core Inhibitor

kcohen profile image
0 Replies

natap.org/2014/AASLD/AASLD_...

Written by
kcohen profile image
kcohen
To view profiles and participate in discussions please or .